4//SEC Filing
SALIX PHARMACEUTICALS LTD 4
Accession 0001209191-13-035577
CIK 0001009356operating
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 4:54 PM ET
Size
8.5 KB
Accession
0001209191-13-035577
Insider Transaction Report
Form 4
LOGAN CAROLYN J
DirectorPresident & CEO
Transactions
- Tax Payment
Common Stock
2013-07-01$66.15/sh−20,113$1,330,475→ 935,460.2 total
Holdings
- 65,625
Option to Buy Common Stock
Exercise: $18.87Exp: 2014-06-17→ Common Stock (65,625 underlying) - 44,000
Option to Buy Common Stock
Exercise: $17.63Exp: 2015-06-09→ Common Stock (44,000 underlying) - 33,750
Option to Buy Common Stock
Exercise: $18.87Exp: 2014-06-17→ Common Stock (33,750 underlying)
Footnotes (2)
- [F1]Does not represent a sale in the market; represents a forfeiture of shares to the Issuer in order to pay tax withholding upon vesting of restricted stock.
- [F2]Options are 100% vested.
Documents
Issuer
SALIX PHARMACEUTICALS LTD
CIK 0001009356
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001009356
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 4:54 PM ET
- Size
- 8.5 KB